CALC Episode 1: From Molecule to Patient: The Statistician’s Role in Developing New Medicines - a podcast by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry
from 2019-10-23T23:01
How do we develop new medicines to treat nasty diseases? It all starts by discovering a novel target molecule in the lab. Fast forward 12 years and an average expenditure of 1.5 billion dollars we hopefully get the thumbs up from health authority bodies to license the medicine for public use.
So we skipped a lot of important steps there. The journey for developing new medicines is extremely lengthy and complicated. Fortunately, you can listen to this podcast and know all the important stuff in 20 minutes!
Statisticians are involved in all aspects of drug development. Having knowledge of the process from start to finish is important, as it will help you understand why statistics is an essential and relied upon toolkit in this industry.
- Quick overview of the drug development process
- Where and why statisticians add value in the process
- Key stakeholder interactions - who do statisticians collaborate with?
Further episodes of The Effective Statistician - in association with PSI
Further podcasts by Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry